MedPath

Clinical Performance of Zirconia Reinforced GI Versus Conventional Viscous GI in Geriatric Patients

Phase 2
Completed
Conditions
Performance
Geriatric
Interventions
Drug: Ketac Molar quick Aplicap
Drug: Zirconomer Improved
Registration Number
NCT04298151
Lead Sponsor
Cairo University
Brief Summary

This study is conducted to evaluate the clinical performance of Zirconomer Improved GI restoration compared to Conventional viscous GI restoration in geriatric patients with Posterior carious lesions in class I or II cavities

Detailed Description

This study will be conducted to determine the clinical performance of the Zirconia reinforced glass ionomer restorations ( Zirconomer improved) under stress bearing posterior area (class I or claa II cavities) in geriatric population in comparison to Conventional viscous glass ionomer restorations (Ketac molar quick Aplicap) using the modified United States Public Health Service (USPHS) criteria

P: Geriatric Patients with posterior Caries lesions I: Zirconia reinforced GI (Zirconomer Improved) C: Conventional viscous GI, (Ketac Molar quick Aplicap) O: The Clinical performance of the Glass Ionomer restorations Using USPHS Criteria

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
28
Inclusion Criteria
  • Age range 60-80 years
  • Geriatric patients with Class I or II Posterior carious lesions.
  • Males or Females.
  • Pulp asymptomatic vital carious posterior teeth.
  • Co-operative patients approving to participate in the trial.
Exclusion Criteria
  • Age range less than 60 years.
  • Disabilities.
  • Deep extensive carious cavities that may lead to fracture of the tooth or pulpal affection.
  • Teeth with signs and symptoms of irreversible pulpitis or pulp necrosis.
  • Heavy smoking.
  • Lack of compliance.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
ketac molar quick aplicapKetac Molar quick Aplicapconventional viscous glass ionomer restoration
zirconomer improvedZirconomer Improvedzirconia reinforced glass ionomer restoration
Primary Outcome Measures
NameTimeMethod
Clinical performance1 year

clinical performance of the Glass Ionomer restorations using modified USPHS criteria

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Doaa Abdou

🇪🇬

Giza, Egypt

© Copyright 2025. All Rights Reserved by MedPath